Resolian, a renowned global leader in providing comprehensive bioanalytical, DMPK, and CMC testing services for the pharmaceutical and biopharmaceutical sectors, has proudly inaugurated its state-of-the-art analytical laboratory spanning 440m² in Fordham, Cambridgeshire, UK.
This much-anticipated lab, whose plans were unveiled earlier this year, offers a 30% increase in space to effectively address the escalating demand for analytical and materials science work.
Ellen Stokvis, the Operations Director for Analytical Sciences, expressed delight, stating, “We are thrilled to have expanded our Fordham laboratory by over 30% to cater to the burgeoning demand. Our newly established, purpose-built, and state-of-the-art lab bolsters our analytical and materials science capabilities. The augmentation of lab space from 330m² to 440m² enables more companies to collaborate with us effectively.”
The newly designed laboratory space is dedicated to facilitating enhanced collaboration, optimising workflow, and ensuring smooth traffic flow. In conjunction with the company’s Sandwich site, this investment in the realm of analytical and materials science positions Resolian perfectly to meet present and future demands from its esteemed clientele.
To learn more about how Resolian continues to evolve and provide specialised support essential throughout the worldwide drug development continuum, visit the company’s newly launched website.